At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Amicus Therapeutics is a biopharmaceutical company with a robust pipeline of novel, first-in-class, small molecules called pharmacological chaperones for the treatment of lysosomal storage diseases.
More...
NEWS
05/14/2013 Amicus Therapeutics to Present at UBS Global Healthcare Conference
05/09/2013 Amicus Therapeutics Announces First Quarter 2013 Financial Results and Corporate Updates
05/02/2013 Amicus Therapeutics to Announce First Quarter 2013 Financial Results on May 9, 2013
More...

What's Missing in Lysosomal Storage Diseases?

About Pharmacological Chaperones

Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy